Nymx

Altro buon prodotto...ma sempre sotto 3,20 :mmmm:

Studies Show that Nymox NXC-4720 Product Can Substantially Reduce E. Coli Meat Contamination
By CCNMatthews 2/24/2005 11:17:22 AM
 
Nymox Pharma`s AlzheimAlert Urine Test`s PMA To Be Presented At FDA Advisory Panel Meeting - Update [NYMX]

4/25/2005 10:08:58 AM Monday morning, Nymox Pharmaceutical Corp. (NYMX), announced that its premarket approval application to FDA, concerning a kit version of AlzheimAlert urine test, would be presented before a panel of the Medical Devices Advisory Committee.

The company reported it would present the premarket approval application (PMA) to FDA concerning a kit version of AlzheimAlert urine test, before a panel of the Medical Devices Advisory Committee. The date for the panel meeting is yet to be confirmed.

In the PMA, Nymox would seek FDA approval to sell kit versions of its test, AlzheimAlert, to qualified laboratories and hospitals in the United States. This proprietary urine test is intended to aid physicians in the diagnosis of Alzheimer's disease.

AlzheimAlert has been already certified as a laboratory testing service in the U.S. through the Company's CLIA - certified clinical reference laboratory. A kit version of AlzheimAlert is also available for sale in Europe as a result of its certification with a CE Mark, making the test kit eligible for sale in the European Union.

NYMX is currently trading at $2.53 per share, up 5 cents.
 
Indietro